Abbares Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 1.00 M
as on 03-07-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 72.01 M
as on 03-07-2024
- Satisfied Charges ₹ 14.97 M
as on 03-07-2024
- Revenue 36.96%
(FY 2022)
- Profit 51.29%
(FY 2022)
- Ebitda 50.63%
(FY 2022)
- Net Worth 34.64%
(FY 2022)
- Total Assets 25.10%
(FY 2022)
About Abbares Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.20 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Seema Bhardwaj, Preksha Bhardwaj, and Rajesh Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U51909RJ2018PTC060761
- Company No.
060761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Abbares Pharmaceuticals?
Board Members(3)
Financial Performance and Corporate Structure Insights of Abbares Pharmaceuticals.
Abbares Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.96% increase. The company also saw a substantial improvement in profitability, with a 51.29% increase in profit. The company's net worth Soared by an impressive increase of 34.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abbares Pharmaceuticals?
In 2022, Abbares Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
4 years 5 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Nov 2023 | ₹3.50 Cr | Open |
Others Creation Date: 18 Oct 2022 | ₹6.80 M | Open |
Others Creation Date: 30 Sep 2022 | ₹2.97 Cr | Open |
How Many Employees Work at Abbares Pharmaceuticals?
Unlock and access historical data on people associated with Abbares Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jun 19, 2019, Abbares Pharmaceuticals has raised a total of ₹ 1.88 M, with the most recent deal valued at ₹ 0.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
